Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Continuous exposure of breast cancer cells to tamoxifen upregulates GPER-1 and increases cell proliferation
doi: 10.1016/j.ebiom.2018.09.015 104 XuQFuQLiZLiuHWangYLinXet al
The Journal of Investigative Dermatology, 113 (3), 364368
Ipamorelin FAQ What is Ipamorelin used for in research
Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist Text PDF Abstract Tirzepatide (LY3298176) is a dual GIP and GLP-1 receptor agonist under development for the treatment of type 2 diabetes mellitus (T2DM), obesity, and nonalcoholic steatohepatitis
Key methods: Extraction of IGE reports labeled under the term impaired gastric emptying in MedDRA
US$ 28.37
.png)
US$ 23.86
US$ 21.61
US$ 28.52
US$ 21.30
US$ 27.12
US$ 23.46
